NeuroSense Therapeutics Ltd. (NRSNW)
Market Open
11 Sep, 13:39
NASDAQ (CM) NASDAQ (CM) Primary $
0. 05
-0
-8%
$
1.23M Market Cap
- P/E Ratio
- Div Yield
1 Volume
0 Eps
$ 0.05
Previous Close Investors:
Want to track NRSNW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NeuroSense Therapeutics Ltd. (NRSNW) Statistics
Valuation metrics
Market Cap 1.23M
Enterprise value 18.06M
Trailing P/E (ttm) -1.15
Forward P/E -
PEG ratio -0.86
Price/Sales (ttm) -
Price/Book (mrq) -8.37
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.63
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.27K
Average volume (90 days) 1.68K
Price summary
52-Week low 0.05
52-Week high 0.3
Beta -
50-Day moving average 0.08
200-Day moving average 0.19
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -10.82%
Return on equity 10.7%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.44
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) -0.11
Current ratio (mrq) 0.31%
Book value per share (mrq) -0.06
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
